Article Text

PDF
Short report
Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease
  1. Simone Baiardi1,
  2. Veronica Redaelli2,
  3. Paolo Ripellino3,
  4. Marcello Rossi4,
  5. Alessia Franceschini4,
  6. Maurizio Moggio5,
  7. Patrizia Sola6,
  8. Anna Ladogana7,
  9. Paolo Fociani8,
  10. Anna Magherini9,
  11. Sabina Capellari1,4,
  12. Armin Giese10,
  13. Byron Caughey11,
  14. Paola Caroppo2,
  15. Piero Parchi4,12
  1. 1 Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
  2. 2 Neurology and Neuropathology Unit, IRCCS, Foundation, Neurological Institute Carlo Besta of Milan, Milano, Italy
  3. 3 Department of Neurology, Neurocenter of Southern Switzerland, Lugano, Switzerland
  4. 4 IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
  5. 5 Neuromuscular and Rare Disease Unit, Department of Neuroscience, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
  6. 6 Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy
  7. 7 Department of Neurosciences, Istituto Superiore di Sanità, Rome, Italy
  8. 8 Department of Pathology, Luigi Sacco University Hospital, Milan, Italy
  9. 9 Neurology Unit, Carlo Poma Hospital, Mantova, Italy
  10. 10 Institut für Neuropathologie und Prion Forschung, Ludwig-Maximilians-Universität München, Munich, Germany
  11. 11 LPVD, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, USA
  12. 12 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Università di Bologna, Bologna, Italy
  1. Correspondence to Professor Piero Parchi, IRCCS Istituto delle Scienze Neurologiche, Bologna 40139, Italy; piero.parchi{at}unibo.it

Abstract

Objective To assess whether the involvement of the peripheral nervous system (PNS) belongs to the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease (sCJD).

Methods We examined medical records of 117 sCJDVV2 (ataxic type), 65 sCJDMV2K (kuru-plaque type) and 121 sCJDMM(V)1 (myoclonic type) subjects for clinical symptoms, objective signs and neurophysiological data. We reviewed two diagnostic nerve biopsies and looked for abnormal prion protein (PrPSc) by western blotting and real-time quaking-induced conversion (RT-QuIC) in postmortem PNS samples from 14 subjects.

Results Seventy-five (41.2%) VV2-MV2K patients, but only 11 (9.1%) MM(V)1, had symptoms or signs suggestive of PNS involvement occurring at onset in 18 cases (17 VV2-MV2K, 9.3%; and 1 MM(V)1, 0.8%) and isolated in 6. Nerve biopsy showed a mixed predominantly axonal and demyelinating neuropathy in two sCJDMV2K. Electromyography showed signs of neuropathy in half of the examined VV2-MV2K patients. Prion RT-QuIC was positive in all CJD PNS samples, whereas western blotting detected PrPSc in the sciatic nerve in one VV2 and one MV2K.

Conclusions Peripheral neuropathy, likely related to PrPSc deposition, belongs to the phenotypic spectrum of sCJDMV2K and VV2 and may mark the clinical onset. The significantly lower prevalence of PNS involvement in typical sCJDMM(V)1 suggests that the PNS tropism of sCJD prions is strain dependent.

  • prion
  • neuropathy
  • peripheral neuropathology
  • creutzfeldt-jakob disease
  • amyloid
  • rapidly progressive dementia

Statistics from Altmetric.com

Footnotes

  • Contributors Study design: SB, PP. Data acquisition: SB, VR, PR, MR, AF, MM, PS, AL, PF, AM, SC, AG, BC, PC, PP. Data analysis and interpretation: SB, MR, AF, PR, PP. Drafting of the manuscript: SB, PP. Study supervision: PP. All authors critically reviewed and approved the manuscript.

  • Funding The study was supported by the Italian Ministry of Health, grant RF2011-02351092, and by the Gino Galletti Foundation.

  • Competing interests None declared.

  • Patient consent Not required.

  • Ethics approval Ethical approval for the study was provided by the Local Ethics Committee (AUSL of Bologna, n. 16184/CE).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data statement The datasets analysed during the present study are available from the corresponding author and will be shared on reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.